Clinical Trial Update: Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

View source ↗

Summary

Italian prospective observational study evaluating the effectiveness and outcomes of Lutathera treatment in patients with gastroenteropancreatic neuroendocrine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumors

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Gastroenteropancreatic Neuroendocrine Tumor | Status: ACTIVE_NOT_RECRUITING